Myriad Genetics, Inc.’s recently made public that its SVP, Chief of Staff Ancona Margaret unloaded Company’s shares for reported $0.32 million on Aug 21 ’24. In the deal valued at $27.82 per share,11,538 shares were sold. As a result of this transaction, Ancona Margaret now holds 79,366 shares worth roughly $2.25 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Kumar Rashmi sold 7,500 shares, generating $210,075 in total proceeds. Upon selling the shares at $28.01, the Director now owns 77,392 shares.
Before that, Kumar Rashmi bought 7,500 shares. Myriad Genetics, Inc. shares valued at $210,075 were divested by the Director at a price of $28.01 per share.
Wells Fargo initiated its Myriad Genetics, Inc. [MYGN] rating to an Overweight in a research note published on August 28, 2024; the price target was $35. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in late June with a ‘”a Sector outperform”‘ rating. Leerink Partners revised its rating on May 08, 2024. It rated MYGN as “an Outperform” which previously was an “a Market perform”.
Price Performance Review of MYGN
On Friday, Myriad Genetics, Inc. [NASDAQ:MYGN] saw its stock jump 0.04% to $28.33. Over the last five days, the stock has gained 0.75%. Myriad Genetics, Inc. shares have risen nearly 48.01% since the year began. Nevertheless, the stocks have risen 55.49% over the past one year. While a 52-week high of $29.08 was reached on 08/29/24, a 52-week low of $13.82 was recorded on 01/08/24. SMA at 50 days reached $26.74, while 200 days put it at $22.47.
Levels Of Support And Resistance For MYGN Stock
The 24-hour chart illustrates a support level at 27.79, which if violated will result in even more drops to 27.25. On the upside, there is a resistance level at 28.92. A further resistance level may holdings at 29.51. The Relative Strength Index (RSI) on the 14-day chart is 58.92, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.26, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 41.21%. Stochastics %K at 54.92% indicates the stock is a holding.
How much short interest is there in Myriad Genetics, Inc.?
A steep rise in short interest was recorded in Myriad Genetics, Inc. stocks on 2024-08-15, growing by 40074.0 shares to a total of 3.88 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-15 was 3.84 million shares. There was a rise of 1.03%, which implies that there is a positive sentiment for the stock.
